Comparable monthly disclosures
Institutional Activity
Where disclosed mutual fund positions are increasing, reducing, opening or closing.
Portfolio increases
Nov 2022 · Ranked across companies with at least 10 comparable portfolios
| Company | Portfolio increases | Comparable change | Portfolios increasing | Portfolios reducing | Comparable portfolios |
|---|---|---|---|---|---|
| BIRLASOFT LIMITED BSOFT | 5 17.9% of comparable | -0.11 Cr | 5 | 7 | 28 |
| Motherson Sumi Wiring India Limited MSUMI | 5 12.5% of comparable | +0.03 Cr | 5 | 8 | 40 |
| UNO Minda Limited UNOMINDA | 5 9.6% of comparable | -0.04 Cr | 5 | 11 | 52 |
| Max Healthcare Institute Limited MAXHEALTH | 5 19.2% of comparable | -0.10 Cr | 5 | 15 | 26 |
| Tube Investments of India Limited TIINDIA | 5 11.1% of comparable | -0.11 Cr | 5 | 17 | 45 |
| CSB Bank Limited CSBBANK | 4 20.0% of comparable | +0.06 Cr | 4 | 0 | 20 |
| Mahanagar Gas Limited MGL | 4 36.4% of comparable | -7,364 | 4 | 1 | 11 |
| Bank of India BANKINDIA | 4 40.0% of comparable | +1.61 Cr | 4 | 1 | 10 |
| Rategain Travel Technologies Limited RATEGAIN | 4 30.8% of comparable | +0.05 Cr | 4 | 1 | 13 |
| Blue Star Limited BLUESTARCO | 4 18.2% of comparable | -71,917 | 4 | 1 | 22 |
| Sundaram Finance Limited SUNDARMFIN | 4 13.8% of comparable | +8,601 | 4 | 1 | 29 |
| Jyothy Labs Limited JYOTHYLAB | 4 36.4% of comparable | -0.02 Cr | 4 | 1 | 11 |
| Sanofi India Limited SANOFI | 4 16.7% of comparable | +787 | 4 | 2 | 24 |
| Sammaan Capital Limited SAMMAANCAP | 4 33.3% of comparable | +0.08 Cr | 4 | 2 | 12 |
| Cholamandalam Financial Holdings Limited CHOLAHLDNG | 4 10.5% of comparable | -71,263 | 4 | 2 | 38 |
| PNC Infratech Limited PNCINFRA | 4 22.2% of comparable | -35,010 | 4 | 2 | 18 |
| Aavas Financiers Limited AAVAS | 4 30.8% of comparable | -16,129 | 4 | 2 | 13 |
| Chemplast Sanmar Limited CHEMPLASTS | 4 19.0% of comparable | +0.04 Cr | 4 | 2 | 21 |
| Computer Age Management Services Limited CAMS | 4 22.2% of comparable | -27,323 | 4 | 2 | 18 |
| Fine Organic Industries Limited FINEORG | 4 28.6% of comparable | +29,363 | 4 | 2 | 14 |
| Avanti Feeds Limited AVANTIFEED | 4 36.4% of comparable | -0.05 Cr | 4 | 2 | 11 |
| Amara Raja Energy & Mobility Limited ARE&M | 4 36.4% of comparable | +0.06 Cr | 4 | 2 | 11 |
| Tatva Chintan Pharma Chem Limited TATVA | 4 28.6% of comparable | +36,990 | 4 | 3 | 14 |
| GlaxoSmithKline Pharmaceuticals Limited GLAXO | 4 30.8% of comparable | -0.01 Cr | 4 | 3 | 13 |
| Pfizer Limited PFIZER | 4 18.2% of comparable | -26,338 | 4 | 3 | 22 |
How to read this activity
Activity compares disclosed positions for economic portfolios observed in both relevant monthly disclosures and adjusts for externally evidenced corporate actions where available.
At least 10 comparable portfolios are required. Companies under corporate-action review are excluded. Counts are unweighted by portfolio size, and share changes are quantities rather than market values; zero counts can appear at the end of a ranking. Breadth change is the change in AMCs holding, and can also reflect reporting coverage.
Full methodology →